Toll-like receptor 1 and 10 polymorphisms, Helicobacter pylori susceptibility and risk of gastric lesions in a high-risk Chinese population

Infection, Genetics and Evolution

Volumn 31, Issue , 2015, Pages 263-269

  Tang, Fu bing ^a   Li, Zhe xuan ^a   Wang, Yu mei ^a   Zhang, Lian ^a   Ma, Jun ling ^a   Zhou, Tong ^a   Zhang, Yang ^a   Gao, Juan juan ^a   Wu, Si ^a   Yang, Tian ^a   You, Wei cheng ^a   Pan, Kai feng ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Genetic polymorphisms; Helicobacter pylori; Precancerous gastric lesions; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10;

ADULT; ARTICLE; ATROPHIC GASTRITIS; CHINESE; CHRONIC ATROPHIC GASTRITIS; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPING TECHNIQUE; HAPLOTYPE; HELICOBACTER INFECTION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INFECTION SENSITIVITY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH LESION; TLR1 GENE; TLR10 GENE; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MIDDLE AGED; ODDS RATIO; PATHOLOGY; RISK FACTOR; STOMACH DISEASES; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STOMACH DISEASES; STOMACH NEOPLASMS; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 10;

EID: 84923198332     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2015.02.005     Document Type: Article

References (43)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Andersson T., Alfredsson L., Kallberg H., Zdravkovic S., Ahlbom A. Calculating measures of biological interaction. Eur. J. Epidemiol. 2005, 20:575-579.
3. Bardhan P.K. Epidemiological features of Helicobacter pylori infection in developing countries. Clin. Infect. Dis. 1997, 25:973-978.
4. Bell J.K., Mullen G.E.D., Leifer C.A., Mazzoni A., Davies D.R., Segal D.M. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 2003, 24:528-533.
5. Cabrera-Andrade A., Lopez-Cortes A., Munoz M.J., Jaramillo-Koupermann G., Rodriguez O., Leone P.E., Paz Y.M.C. Association of genetic variants of membrane receptors related to recognition and induction of immune response with Helicobacter pylori infection in Ecuadorian individuals. Int. J. Immunogenet. 2014, 41:281-288.
6. Castaño-Rodriguez N., Kaakoush N.O., Mitchell H.M. Pattern recognition receptors and gastric cancer. Front. Immunol. 2014, 5:336.
7. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988, 48:3554-3560.
8. Correa P., Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007, 133:659-672.
9. Dixon M.F., Genta R.M., Yardley J.H., Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996, 20:1161-1181.
10. Gay N.J., Symmons M.F., Gangloff M., Bryant C.E. Assembly and localization of Toll-like receptor signalling complexes. Nat. Rev. Immunol. 2014, 14:546-558.
11. Hamann L., Bedu-Addo G., Eggelte T.A., Schumann R.R., Mockenhaupt F.P. The toll-like receptor 1 variant S248N influences placental malaria. Infect. Genet. Evol. 2010, 10:785-789.
12. Hasan U., Chaffois C., Gaillard C., Saulnier V., Merck E., Tancredi S., Guiet C., Brière F., Vlach J., Lebecque S. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J. Immunol. 2005, 174:2942-2950.
13. Hellmig S. Influence of ethnic background on genetic susceptibility to H. pylori infection. Eur. J. Gastroenterol. Hepatol. 2007, 19:730-731.
14. Johnson C.M., Lyle E.A., Omueti K.O., Stepensky V.A., Yegin O., Alpsoy E., Hamann L., Schumann R.R., Tapping R.I. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 2007, 178:7520-7524.
15. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
16. 13C urea breath test. Am. J. Gastroenterol. 1996, 91:690-694.
17. Kusters J.G., van Vliet A.H., Kuipers E.J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006, 19:449-490.
18. Kutikhin A.G. Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk. Hum. Immunol. 2011, 72:1095-1116.
19. Ma J.L., Zhang L., Brown L.M., Li J.Y., Shen L., Pan K.F., Liu W.D., Hu Y., Han Z.X., Crystal-Mansour S., Pee D., Blot W.J., Fraumeni J.F., You W.C., Gail M.H. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J. Natl Cancer Inst. 2012, 104:488-492.
20. Mayerle J., den Hoed C.M., Schurmann C., Stolk L., Homuth G., Peters M.J., Capelle L.G., Zimmermann K., Rivadeneira F., Gruska S., Volzke H., de Vries A.C., Volker U., Teumer A., van Meurs J.B., Steinmetz I., Nauck M., Ernst F., Weiss F.U., Hofman A., Zenker M., Kroemer H.K., Prokisch H., Uitterlinden A.G., Lerch M.M., Kuipers E.J. Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 2013, 309:1912-1920.
21. Mikacenic C., Reiner A.P., Holden T.D., Nickerson D.A., Wurfel M.M. Variation in the TLR10/TLR1/TLR6 locus is the major genetic determinant of interindividual difference in TLR1/2-mediated responses. Genes Immun. 2013, 14:52-57.
22. Netea M.G., Wijmenga C., O'Neill L.A. Genetic variation in Toll-like receptors and disease susceptibility. Nat. Immunol. 2012, 13:535-542.
23. Omueti K.O., Mazur D.J., Thompson K.S., Lyle E.A., Tapping R.I. The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J. Immunol. 2007, 178:6387-6394.
24. Oosting M., Cheng S.C., Bolscher J.M., Vestering-Stenger R., Plantinga T.S., Verschueren I.C., Arts P., Garritsen A., van Eenennaam H., Sturm P., Kullberg B.J., Hoischen A., Adema G.J., van der Meer J.W., Netea M.G., Joosten L.A. Human TLR10 is an anti-inflammatory pattern-recognition receptor. Proc. Natl. Acad. Sci. U.S.A 2014, 111:E4478-4484.
25. Park H.J., Hahn W.H., Suh J.S., Kim M.J., Kang S.W., Lee J.S., Kim J.W., Chung J.H., Cho B.S. Association between toll-like receptor 10 (TLR10) gene polymorphisms and childhood IgA nephropathy. Eur. J. Pediatr. 2011, 170:503-509.
26. Peek R.M., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2002, 2:28-37.
27. Pino-Yanes M., Corrales A., Casula M., Blanco J., Muriel A., Espinosa E., Garcia-Bello M., Torres A., Ferrer M., Zavala E., Villar J., Flores C. Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsis. PLoS One 2010, 5:e13759.
28. Plantinga T.S., Johnson M.D., Scott W.K., van de Vosse E., Velez Edwards D.R., Smith P.B., Alexander B.D., Yang J.C., Kremer D., Laird G.M., Oosting M., Joosten L.A., van der Meer J.W., van Dissel J.T., Walsh T.J., Perfect J.R., Kullberg B.J., Netea M.G. Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J. Infect. Dis. 2012, 205:934-943.
29. Rugge M., Correa P., Dixon M.F., Hattori T., Leandro G., Lewin K., Riddell R.H., Sipponen P., Watanabe H. Gastric dysplasia: the Padova international classification. Am. J. Surg. Pathol. 2000, 24:167-176.
30. Schroder N.W., Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 2005, 5:156-164.
31. Schuring R.P., Hamann L., Faber W.R., Pahan D., Richardus J.H., Schumann R.R., Oskam L. Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J. Infect. Dis. 2009, 199:1816-1819.
32. Smith M.F., Mitchell A., Li G., Ding S., Fitzmaurice A.M., Ryan K., Crowe S., Goldberg J.B. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-κB activation and chemokine expression by epithelial cells. J. Biol. Chem. 2003, 278:32552-32560.
33. Stappers M.H., Thys Y., Oosting M., Plantinga T.S., Ioana M., Reimnitz P., Mouton J.W., Netea M.G., Joosten L.A., Gyssens I.C. TLR1, TLR2, and TLR6 gene polymorphisms are associated with increased susceptibility to complicated skin and skin structure infections. J. Infect. Dis. 2014, 210:311-318.
34. Suerbaum S., Michetti P. Helicobacter pylori infection. N. Engl. J. Med. 2002, 347:1175-1186.
35. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
36. Wong B.C., Zhang L., Ma J.L., Pan K.F., Li J.Y., Shen L., Liu W.D., Feng G.S., Zhang X.D., Li J., Lu A.P., Xia H.H., Lam S., You W.C. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 2012, 61:812-818.
37. Wurfel M.M., Gordon A.C., Holden T.D., Radella F., Strout J., Kajikawa O., Ruzinski J.T., Rona G., Black R.A., Stratton S., Jarvik G.P., Hajjar A.M., Nickerson D.A., Rieder M., Sevransky J., Maloney J.P., Moss M., Martin G., Shanholtz C., Garcia J.G., Gao L., Brower R., Barnes K.C., Walley K.R., Russell J.A., Martin T.R. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am. J. Respir. Crit. Care Med. 2008, 178:710-720.
38. Wurfel M.M., Hawn T.R. Genetic variants associated with susceptibility to Helicobacter pylori. JAMA 2013, 310:976.
39. Yang C.A., Scheibenbogen C., Bauer S., Kleinle C., Wex T., Bornschein J., Malfertheiner P., Hellmig S., Schumann R.R., Hamann L. A frequent Toll-like receptor 1 gene polymorphism affects NK- and T-cell IFN-gamma production and is associated with Helicobacter pylori-induced gastric disease. Helicobacter 2013, 18:13-21.
40. You W.C., Brown L.M., Zhang L., Li J.Y., Jin M.L., Chang Y.S., Ma J.L., Pan K.F., Liu W.D., Hu Y., Crystal-Mansour S., Pee D., Blot W.J., Fraumeni J.F., Xu G.W., Gail M.H. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J. Natl Cancer Inst. 2006, 98:974-983.
41. You W.C., Hong J.Y., Zhang L., Pan K.F., Pee D., Li J.Y., Ma J.L., Rothman N., Caporaso N., Fraumeni J.F., Xu G.W., Gail M.H. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population. Cancer Epidemiol. Biomarkers Prev. 2005, 14:451-458.
42. You W.C., Zhang L., Gail M.H., Ma J.L., Chang Y.S., Blot W.J., Li J.Y., Zhao C.L., Liu W.D., Li H.Q. Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer. Int. J. Epidemiol. 1998, 27:941-944.
43. Zeng H.M., Pan K.F., Zhang Y., Zhang L., Ma J.L., Zhou T., Su H.J., Li W.Q., Li J.Y., Gerhard M., Classen M., You W.C. Genetic variants of Toll-like receptor 2 and 5, Helicobacter pylori infection, and risk of gastric cancer and its precursors in a Chinese population. Cancer Epidemiol. Biomarkers Prev. 2011, 20:2594-2602.